カテゴリ： QYResearch, 世界, 医療/バイオ

ファモチジン医薬品の世界市場2023年：錠剤、注射剤、その他

■ 英語タイトル：Global Famotidine Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8758）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8758
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ファモチジン医薬品の世界市場2023年：錠剤、注射剤、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はファモチジン医薬品のグローバル市場について調査・分析し、世界のファモチジン医薬品市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（錠剤、注射剤、その他）、用途別セグメント分析（病院、薬局）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Merck & Co、Yamanouchi Pharmaceutical、Astellas Pharma Inc.、Xiuzheng Pharmaceutical、Fujian Tianquan Pharmaceutical、Sansheng Shares、PIDIなどが含まれています。ファモチジン医薬品のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ファモチジン医薬品市場規模を算出する際に考慮しました。

・ファモチジン医薬品市場の概要
- 製品の定義
- ファモチジン医薬品の種類別セグメント
- 世界のファモチジン医薬品市場規模：タイプ別分析（錠剤、注射剤、その他）
- ファモチジン医薬品の用途別セグメント
- 世界のファモチジン医薬品市場規模：用途別分析（病院、薬局）
- 世界のファモチジン医薬品市場規模予測（2018年-2029年）
- ファモチジン医薬品の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ファモチジン医薬品市場の競争状況およびトレンド

・ファモチジン医薬品の地域別市場規模
- 北米のファモチジン医薬品市場規模（2018年-2029年）
- 米国のファモチジン医薬品市場規模（2018年-2029年）
- ヨーロッパのファモチジン医薬品市場規模（2018年-2029年）
- アジア太平洋のファモチジン医薬品市場規模（2018年-2029年）
- 中国のファモチジン医薬品市場規模（2018年-2029年）
- 日本のファモチジン医薬品市場規模（2018年-2029年）
- 韓国のファモチジン医薬品市場規模（2018年-2029年）
- インドのファモチジン医薬品市場規模（2018年-2029年）
- オーストラリアのファモチジン医薬品市場規模（2018年-2029年）
- 中南米のファモチジン医薬品市場規模（2018年-2029年）
- 中東・アフリカのファモチジン医薬品市場規模（2018年-2029年）

・種類別セグメント：錠剤、注射剤、その他
- 世界のファモチジン医薬品のタイプ別販売量（2018年-2023年）
- 世界のファモチジン医薬品のタイプ別売上（2018年-2023年）
- 世界のファモチジン医薬品のタイプ別価格

・用途別セグメント：病院、薬局
- 世界のファモチジン医薬品の用途別販売量（2018年-2023年）
- 世界のファモチジン医薬品の用途別売上（2018年-2023年）
- 世界のファモチジン医薬品の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Merck & Co、Yamanouchi Pharmaceutical、Astellas Pharma Inc.、Xiuzheng Pharmaceutical、Fujian Tianquan Pharmaceutical、Sansheng Shares、PIDI

・産業チェーンと販売チャネルの分析
- ファモチジン医薬品産業チェーン分析
- ファモチジン医薬品の主要原材料
- ファモチジン医薬品の販売チャネル
- ファモチジン医薬品のディストリビューター
- ファモチジン医薬品の主要顧客

・ファモチジン医薬品市場ダイナミクス
- ファモチジン医薬品の業界動向
- ファモチジン医薬品市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Famotidine Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Famotidine Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Famotidine Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Famotidine Drugs include Merck & Co, Yamanouchi Pharmaceutical, Astellas Pharma Inc., Xiuzheng Pharmaceutical, Fujian Tianquan Pharmaceutical, Sansheng Shares and PIDI, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Famotidine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famotidine Drugs.
The Famotidine Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Famotidine Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famotidine Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck & Co
Yamanouchi Pharmaceutical
Astellas Pharma Inc.
Xiuzheng Pharmaceutical
Fujian Tianquan Pharmaceutical
Sansheng Shares
PIDI
Segment by Type
Tablets
Injection
Others
Segment by Application
Hospital
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famotidine Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famotidine Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Famotidine Drugs Market Overview
1.1 Product Overview and Scope of Famotidine Drugs
1.2 Famotidine Drugs Segment by Type
1.2.1 Global Famotidine Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Tablets
1.2.3 Injection
1.2.4 Others
1.3 Famotidine Drugs Segment by Application
1.3.1 Global Famotidine Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Famotidine Drugs Market Size Estimates and Forecasts
1.4.1 Global Famotidine Drugs Revenue 2018-2029
1.4.2 Global Famotidine Drugs Sales 2018-2029
1.4.3 Global Famotidine Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Famotidine Drugs Market Competition by Manufacturers
2.1 Global Famotidine Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Famotidine Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Famotidine Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Famotidine Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Famotidine Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Famotidine Drugs, Product Type & Application
2.7 Famotidine Drugs Market Competitive Situation and Trends
2.7.1 Famotidine Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Famotidine Drugs Players Market Share by Revenue
2.7.3 Global Famotidine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Famotidine Drugs Retrospective Market Scenario by Region
3.1 Global Famotidine Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Famotidine Drugs Global Famotidine Drugs Sales by Region: 2018-2029
3.2.1 Global Famotidine Drugs Sales by Region: 2018-2023
3.2.2 Global Famotidine Drugs Sales by Region: 2024-2029
3.3 Global Famotidine Drugs Global Famotidine Drugs Revenue by Region: 2018-2029
3.3.1 Global Famotidine Drugs Revenue by Region: 2018-2023
3.3.2 Global Famotidine Drugs Revenue by Region: 2024-2029
3.4 North America Famotidine Drugs Market Facts & Figures by Country
3.4.1 North America Famotidine Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Famotidine Drugs Sales by Country (2018-2029)
3.4.3 North America Famotidine Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Famotidine Drugs Market Facts & Figures by Country
3.5.1 Europe Famotidine Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Famotidine Drugs Sales by Country (2018-2029)
3.5.3 Europe Famotidine Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Famotidine Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Famotidine Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Famotidine Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Famotidine Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Famotidine Drugs Market Facts & Figures by Country
3.7.1 Latin America Famotidine Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Famotidine Drugs Sales by Country (2018-2029)
3.7.3 Latin America Famotidine Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Famotidine Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Famotidine Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Famotidine Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Famotidine Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Famotidine Drugs Sales by Type (2018-2029)
4.1.1 Global Famotidine Drugs Sales by Type (2018-2023)
4.1.2 Global Famotidine Drugs Sales by Type (2024-2029)
4.1.3 Global Famotidine Drugs Sales Market Share by Type (2018-2029)
4.2 Global Famotidine Drugs Revenue by Type (2018-2029)
4.2.1 Global Famotidine Drugs Revenue by Type (2018-2023)
4.2.2 Global Famotidine Drugs Revenue by Type (2024-2029)
4.2.3 Global Famotidine Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Famotidine Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Famotidine Drugs Sales by Application (2018-2029)
5.1.1 Global Famotidine Drugs Sales by Application (2018-2023)
5.1.2 Global Famotidine Drugs Sales by Application (2024-2029)
5.1.3 Global Famotidine Drugs Sales Market Share by Application (2018-2029)
5.2 Global Famotidine Drugs Revenue by Application (2018-2029)
5.2.1 Global Famotidine Drugs Revenue by Application (2018-2023)
5.2.2 Global Famotidine Drugs Revenue by Application (2024-2029)
5.2.3 Global Famotidine Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Famotidine Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck & Co
6.1.1 Merck & Co Corporation Information
6.1.2 Merck & Co Description and Business Overview
6.1.3 Merck & Co Famotidine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck & Co Famotidine Drugs Product Portfolio
6.1.5 Merck & Co Recent Developments/Updates
6.2 Yamanouchi Pharmaceutical
6.2.1 Yamanouchi Pharmaceutical Corporation Information
6.2.2 Yamanouchi Pharmaceutical Description and Business Overview
6.2.3 Yamanouchi Pharmaceutical Famotidine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Yamanouchi Pharmaceutical Famotidine Drugs Product Portfolio
6.2.5 Yamanouchi Pharmaceutical Recent Developments/Updates
6.3 Astellas Pharma Inc.
6.3.1 Astellas Pharma Inc. Corporation Information
6.3.2 Astellas Pharma Inc. Description and Business Overview
6.3.3 Astellas Pharma Inc. Famotidine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Astellas Pharma Inc. Famotidine Drugs Product Portfolio
6.3.5 Astellas Pharma Inc. Recent Developments/Updates
6.4 Xiuzheng Pharmaceutical
6.4.1 Xiuzheng Pharmaceutical Corporation Information
6.4.2 Xiuzheng Pharmaceutical Description and Business Overview
6.4.3 Xiuzheng Pharmaceutical Famotidine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xiuzheng Pharmaceutical Famotidine Drugs Product Portfolio
6.4.5 Xiuzheng Pharmaceutical Recent Developments/Updates
6.5 Fujian Tianquan Pharmaceutical
6.5.1 Fujian Tianquan Pharmaceutical Corporation Information
6.5.2 Fujian Tianquan Pharmaceutical Description and Business Overview
6.5.3 Fujian Tianquan Pharmaceutical Famotidine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fujian Tianquan Pharmaceutical Famotidine Drugs Product Portfolio
6.5.5 Fujian Tianquan Pharmaceutical Recent Developments/Updates
6.6 Sansheng Shares
6.6.1 Sansheng Shares Corporation Information
6.6.2 Sansheng Shares Description and Business Overview
6.6.3 Sansheng Shares Famotidine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Sansheng Shares Famotidine Drugs Product Portfolio
6.6.5 Sansheng Shares Recent Developments/Updates
6.7 PIDI
6.6.1 PIDI Corporation Information
6.6.2 PIDI Description and Business Overview
6.6.3 PIDI Famotidine Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 PIDI Famotidine Drugs Product Portfolio
6.7.5 PIDI Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Famotidine Drugs Industry Chain Analysis
7.2 Famotidine Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Famotidine Drugs Production Mode & Process
7.4 Famotidine Drugs Sales and Marketing
7.4.1 Famotidine Drugs Sales Channels
7.4.2 Famotidine Drugs Distributors
7.5 Famotidine Drugs Customers
8 Famotidine Drugs Market Dynamics
8.1 Famotidine Drugs Industry Trends
8.2 Famotidine Drugs Market Drivers
8.3 Famotidine Drugs Market Challenges
8.4 Famotidine Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Famotidine Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Famotidine Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Famotidine Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Famotidine Drugs Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Famotidine Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Famotidine Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Famotidine Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Famotidine Drugs Average Price (US$/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Famotidine Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Famotidine Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Famotidine Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Famotidine Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Famotidine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Famotidine Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Famotidine Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Famotidine Drugs Sales by Region (2018-2023) & (K MT)
Table 18. Global Famotidine Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Famotidine Drugs Sales by Region (2024-2029) & (K MT)
Table 20. Global Famotidine Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Famotidine Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Famotidine Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Famotidine Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Famotidine Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Famotidine Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Famotidine Drugs Sales by Country (2018-2023) & (K MT)
Table 27. North America Famotidine Drugs Sales by Country (2024-2029) & (K MT)
Table 28. North America Famotidine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Famotidine Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Famotidine Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Famotidine Drugs Sales by Country (2018-2023) & (K MT)
Table 32. Europe Famotidine Drugs Sales by Country (2024-2029) & (K MT)
Table 33. Europe Famotidine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Famotidine Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Famotidine Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Famotidine Drugs Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Famotidine Drugs Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Famotidine Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Famotidine Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Famotidine Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Famotidine Drugs Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Famotidine Drugs Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Famotidine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Famotidine Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Famotidine Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Famotidine Drugs Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Famotidine Drugs Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Famotidine Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Famotidine Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Famotidine Drugs Sales (K MT) by Type (2018-2023)
Table 51. Global Famotidine Drugs Sales (K MT) by Type (2024-2029)
Table 52. Global Famotidine Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Famotidine Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Famotidine Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Famotidine Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Famotidine Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Famotidine Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Famotidine Drugs Price (US$/MT) by Type (2018-2023)
Table 59. Global Famotidine Drugs Price (US$/MT) by Type (2024-2029)
Table 60. Global Famotidine Drugs Sales (K MT) by Application (2018-2023)
Table 61. Global Famotidine Drugs Sales (K MT) by Application (2024-2029)
Table 62. Global Famotidine Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Famotidine Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Famotidine Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Famotidine Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Famotidine Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Famotidine Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Famotidine Drugs Price (US$/MT) by Application (2018-2023)
Table 69. Global Famotidine Drugs Price (US$/MT) by Application (2024-2029)
Table 70. Merck & Co Corporation Information
Table 71. Merck & Co Description and Business Overview
Table 72. Merck & Co Famotidine Drugs Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 73. Merck & Co Famotidine Drugs Product
Table 74. Merck & Co Recent Developments/Updates
Table 75. Yamanouchi Pharmaceutical Corporation Information
Table 76. Yamanouchi Pharmaceutical Description and Business Overview
Table 77. Yamanouchi Pharmaceutical Famotidine Drugs Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 78. Yamanouchi Pharmaceutical Famotidine Drugs Product
Table 79. Yamanouchi Pharmaceutical Recent Developments/Updates
Table 80. Astellas Pharma Inc. Corporation Information
Table 81. Astellas Pharma Inc. Description and Business Overview
Table 82. Astellas Pharma Inc. Famotidine Drugs Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 83. Astellas Pharma Inc. Famotidine Drugs Product
Table 84. Astellas Pharma Inc. Recent Developments/Updates
Table 85. Xiuzheng Pharmaceutical Corporation Information
Table 86. Xiuzheng Pharmaceutical Description and Business Overview
Table 87. Xiuzheng Pharmaceutical Famotidine Drugs Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 88. Xiuzheng Pharmaceutical Famotidine Drugs Product
Table 89. Xiuzheng Pharmaceutical Recent Developments/Updates
Table 90. Fujian Tianquan Pharmaceutical Corporation Information
Table 91. Fujian Tianquan Pharmaceutical Description and Business Overview
Table 92. Fujian Tianquan Pharmaceutical Famotidine Drugs Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 93. Fujian Tianquan Pharmaceutical Famotidine Drugs Product
Table 94. Fujian Tianquan Pharmaceutical Recent Developments/Updates
Table 95. Sansheng Shares Corporation Information
Table 96. Sansheng Shares Description and Business Overview
Table 97. Sansheng Shares Famotidine Drugs Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 98. Sansheng Shares Famotidine Drugs Product
Table 99. Sansheng Shares Recent Developments/Updates
Table 100. PIDI Corporation Information
Table 101. PIDI Description and Business Overview
Table 102. PIDI Famotidine Drugs Sales (K MT), Revenue (US$ Million), Price (US$/MT) and Gross Margin (2018-2023)
Table 103. PIDI Famotidine Drugs Product
Table 104. PIDI Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Famotidine Drugs Distributors List
Table 108. Famotidine Drugs Customers List
Table 109. Famotidine Drugs Market Trends
Table 110. Famotidine Drugs Market Drivers
Table 111. Famotidine Drugs Market Challenges
Table 112. Famotidine Drugs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Famotidine Drugs
Figure 2. Global Famotidine Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Famotidine Drugs Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Injection Product Picture
Figure 6. Others Product Picture
Figure 7. Global Famotidine Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Famotidine Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Global Famotidine Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Famotidine Drugs Market Size (2018-2029) & (US$ Million)
Figure 13. Global Famotidine Drugs Sales (2018-2029) & (K MT)
Figure 14. Global Famotidine Drugs Average Price (US$/MT) & (2018-2029)
Figure 15. Famotidine Drugs Report Years Considered
Figure 16. Famotidine Drugs Sales Share by Manufacturers in 2022
Figure 17. Global Famotidine Drugs Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Famotidine Drugs Players: Market Share by Revenue in 2022
Figure 19. Famotidine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Famotidine Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Famotidine Drugs Sales Market Share by Country (2018-2029)
Figure 22. North America Famotidine Drugs Revenue Market Share by Country (2018-2029)
Figure 23. United States Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Famotidine Drugs Sales Market Share by Country (2018-2029)
Figure 26. Europe Famotidine Drugs Revenue Market Share by Country (2018-2029)
Figure 27. Germany Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Famotidine Drugs Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Famotidine Drugs Revenue Market Share by Region (2018-2029)
Figure 34. China Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Famotidine Drugs Sales Market Share by Country (2018-2029)
Figure 44. Latin America Famotidine Drugs Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Famotidine Drugs Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Famotidine Drugs Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Famotidine Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Famotidine Drugs by Type (2018-2029)
Figure 54. Global Revenue Market Share of Famotidine Drugs by Type (2018-2029)
Figure 55. Global Famotidine Drugs Price (US$/MT) by Type (2018-2029)
Figure 56. Global Sales Market Share of Famotidine Drugs by Application (2018-2029)
Figure 57. Global Revenue Market Share of Famotidine Drugs by Application (2018-2029)
Figure 58. Global Famotidine Drugs Price (US$/MT) by Application (2018-2029)
Figure 59. Famotidine Drugs Value Chain
Figure 60. Famotidine Drugs Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医薬品用ファモチジンのグローバル市場2023：純度≧99%、純度<99%
  • うつ病治療薬の世界市場2023年：SSRI、SNRI、その他
  • 医薬品のグローバル市場展望 2023年-2029年：ブランド医薬品、ジェネリック医薬品
  • 慢性疼痛管理薬の世界市場2023年：オピオイド、非麻薬性鎮痛薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8758 )"ファモチジン医薬品の世界市場2023年：錠剤、注射剤、その他" (英文：Global Famotidine Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。